Collaboration Details

Title of Collaborative Activity:

Policies and Regulatory Pathways to FDA Licensure

Description of Collaborative Activity:

The purpose of this meeting was to understand the policies that advance radiation countermeasure agents and biodosimetry devices towards eventual Food and Drug Administration (FDA) approval. Manuscript preparation is ongoing with input from all agencies, with anticipated submission to Radiation Research

Type of Collaborative Activity:

Other

Year the Collaborative Activity Originated:

2018

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA